~" In this study, 417 patients undergoing "clean" elective neurosurgical operative procedures were randomized to receive a broad-spectrum antibiotic (piperacillin) or placebo given as three perioperative doses, each 6 hours apart. Randomization was carried out by hospital pharmacists, and the investigators remained blinded until the end of the study. Twenty cases were excluded from analysis because either an unforeseen second operation was performed or antibiotic therapy was initiated within 30 days after surgery to treat infection or the risk of infection. Twelve of the 205 patients treated with placebo developed postoperative wound sepsis, and four of the 192 piperacillin-treated patients developed wound sepsis --a statistically significant difference (p < 0.05, Fisher's exact test). Piperacillin thus appeared to reduce the incidence of neurosurgical wound infection in this study.
S
INCE the pioneering animal experiments of Burke 2 in 196 l, the role of perioperative prophylactic antibiotic drugs has been debated in a number of surgical disciplines. 4 '7,17,18 Good evidence now exists that a perioperative prophylactic antibiotic course can substantially reduce sepsis rates in many branches of surgery, particularly orthopedic surgery where metal implants may be inserte& 't7 and abdominal surgery where septic or potentially septic viscera may be breached/8 In neurosurgery, the role of perioperative antibiotic prophylaxis has not yet been clearly established, 8'9 even though several trials have been reported. 1'5'6'8'11't2'15 '16'19 The majority of these studies have defects, and are thus inconclusive. The infection rates currently reported from several centers are still high (approximately 2% to 4%). 8 A blind placebocontrolled randomized study was devised to find out whether a broad-spectrum antibiotic drug, administered perioperatively, would reduce the incidence of postoperative wound infection in neurosurgical patients.
Clinical Material and Methods
Only patients undergoing an elective neurosurgical procedure during normal working hours were entered into the study. The antibiotic solution or placebo (saline) was made up by the hospital dispensary into identical numbered minibags. The allocation of antibiotic or placebo was carried out using a random number list. Numbered minibags were kept refrigerated in the operating room, the first dose of antibiotic drug or placebo being given prior to induction of anesthesia, as soon as the patient entered the operating suite. Thus, the administration of antibiotic drug or placebo was commenced between 30 and 60 minutes prior to the first surgical incision so that peak blood levels of antibiotic were reached during the operation. 3 Two further doses of antibiotic drug or placebo were administered, 6 and 12 hours later. The antibiotic selected was piperacillin sodium, 2 gin, dissolved in 50 ml of 5 % dextrose in water. The antibiotic or placebo was administered at the rate of 35 mg/kg over 15 to 20 minutes as intravenous infusion, given separately from other intravenous medication. Trial medication was stored in a refrigerator for a maximum of 7 days prior to administration.
The patients' wounds were examined at 5, 10, and 30 to 90 days after surgery, and clinical details were recorded on computer forms. Sepsis was recorded when any one of the following three situations was present: l) purulent discharge from a wound; 2) development of clinical features of meningitis, verified by a low sugar and high polymorphonuclear lymphocyte count at lum-bar puncture; or 3) pure culture of organisms from a wound exudate when redness was present. A wound that was red but remained free of exudate was not considered to be definitely infected, but was kept under close observation.
The following categories of patients were not entered in the study: 1) patients with known piperacillin hypersensitivity or allergy; 2) patients who had undergone a neurosurgical operation within a month prior to the study; and 3) patients who had received any antibiotic therapy within 7 days prior to the study.
Continuous data on the condition of the wounds and septic reactions were collected and evaluated using Student's t-test. Although the data were not initially assumed to be normally distributed, the t-test was used because sample sizes were sufficiently large and the assumption of normality could be made according to the central limit theorem. In the case of categorical data, Fisher's exact test was used for 2 • 2 contingency tables while a chi-square test was used for R • C contingency tables with R > 2 and/or C > 2.
Results

Patient Groups
A total of 417 patients were randomly assigned to receive antibiotic or placebo treatment during the 2-year period of the trial. The majority of the patients were operated on by one neurosurgical unit, with two senior surgeons and a number of resident staff. Table 1 outlines the characteristics of the piperacillin-and placebo-treated patient groups. Particular note was taken of factors which may have influenced the occurrence of sepsis, such as operating time and duration of wound drainage. Comparison of the variables in the two groups by means of t-tests and chi-square tests did not show a significant difference between the two groups. Thus, the treatment and placebo groups were well matched. Table 2 shows the incidence of sepsis for each group, and Table 3 outlines the type of operation and sepsis rates for each kind of procedure. The indications of craniotomy or posterior fossa craniectomy included clipping of intracranial aneurysms, removal of arterio- venous malformations, and removal or biopsy of benign and malignant neoplasms. Each of the 63 patients grouped under the category of laminectomy underwent a posterior spinal procedure; this included fenestration for removal of prolapsed intervertebral disc in 26 cases and full laminectomy of conditions such as spinal tumors, spinal stenosis, and syringomyelia in the remaining 37 cases. The 34 patients grouped in Table 3 as having "other" surgery included 20 patients undergoing anterior cervical fusion and 10 who underwent burr-hole procedures such as placement of an Ommaya reservoir or aspiration of tumor-related cysts. When the type of operation was compared between the piperacillin and placebo-treated groups, no significant difference was detected.
Reasons for Exclusion from Study
Twenty patients entered in the study were excluded from final analysis ( Table 4) . No patients were excluded because of adverse drug reaction. One patient developed transient jaundice, but this was not thought to be related to piperacillin treatment. In nine patients, an unforeseen second surgical procedure became necessary within 30 days, and these patients were excluded from further analysis. In l 1 cases, antibiotics were commenced within 30 days after surgery, either because severe infection of the chest or urinary tract intervened, or because a breach of basal air sinuses at the time of surgery induced the operating surgeon to commence antibiotic prophylaxis. When the numbers of patients excluded in the piperacillin-treated group were compared by a chi-square test with those excluded in the placebo group, no statistically significant difference was detected. Patients excluded from analysis were thus evenly distributed between the placebo and piperacillin groups.
Protocol Deviations
In 13 patients, either the documentation was inadequate, the follow-up period was incomplete, or errors were made in the correct timing of drug administration. Four of these cases were in the piperacillin-treated group, and nine were in the placebo group. Twentytwo patients died within 30 days of surgery, but in none of these patients was any signs of wound infection present. Ten of these patients were in the piperacillintreated group, and 12 were in the placebo group (Table  5) . Statistical analysis was performed both including and excluding these 35 protocol deviations, but this made no difference to the significance of the difference in sepsis rates between the piperacillin-and placebotreated groups.
Incidence of Postoperative Sepsis
When the overall incidence of sepsis was compared in the piperacillin-treated patients and in those treated with placebo, a statistically significant reduction was demonstrated (Fisher's exact test, Table 2 ). This was apparent at the 95% confidence level. Piperacillin thus achieved a greater than 50% reduction in the incidence of sepsis. This was most apparent in patients who underwent craniotomy and in those with ventriculoperitoneal shunting (Table 3) . Significance was calculated including the 35 patients with protocol deviations (Table 5) .
Details of the organisms responsible for sepsis in the 16 patients with infection are outlined in Table 6 . Two patients in the placebo-treated group died from their infection. A third patient in the placebo group who underwent craniotomy and developed wound and bone sepsis remained severely disabled as a result of intracranial infection caused by multiple resistant Gram-negative organisms. In three patients, an organism could not be cultured from the exudates of an obviously infected wound. Four patients were infected with Gram-negative organisms, and in two of the three most virulent cases of sepsis, Gram-negative organisms were responsible. Four of the 13 organisms cultured were resistant to piperacillin, but this was more frequent in the placebotreated group than in those who received piperacillin. The relationship of the duration of surgery and postoperative drainage time to the incidence of sepsis was tested using chi-square tests. No significant relationship was found.
Discussion
This study has demonstrated that a broad-spectrum antibiotic drug, given perioperatively, can reduce the incidence of postoperative neurosurgical wound infection. None of the four patients in the piperacillin group sustained permanent sequelae as a result of their sepsis, while in the placebo-treated group two patients died and one remained permanently disabled as a result of sepsis. This trial has supported the findings of other authors that perioperative prophylactic antibiotics can reduce the infection rate in clean neurosurgical procedures. 6'~~ In contrast to most of these other studies, this trial was prospectively randomized and placebocontrolled, thus avoiding many of the sources of bias inherent in such investigations.
Prior to the introduction of this trial, the prevailing sepsis rate in our institution for clean neurosurgical cases ranged between 2% and 5%, and the respective sepsis rates for patients enrolled in this trial were 2% for antibiotic-treated patients and 5.8% for those given placebo. Although sepsis rates in our institution may be higher than those reported from other centers, this may reflect the fact that 15% of our admissions enter the neurosurgical unit with established septic conditions, such as brain abscess, empyema, and septic depression fractures.
Although 4.7% of the cases entered in this study were not included for final analysis, these excluded cases were uniformly distributed between the piperacillin and the placebo groups, so this factor would be unlikely to influence the trial outcome. Similarly, deviations from the trial protocol were noted in 25 patients (Table 6) . Again, these cases were evenly distributed between the piperacillin-and placebo-treated groups, and statistical analysis showed no difference either including or excluding these 25 cases.
The serious consequences of sepsis in surgical specialties such as orthopedics and cardiovascular surgery have prompted the almost universal introduction of high-dose perioperative antibiotic prophylaxis in these two disciplines. 4'v'8'~7 Although many of these surgeons have been at pains to emphasize the importance of scrupulous asepsis in the operating room, tissue handling techniques, and the use of laminar flow techniques, they have adopted perioperative antibiotic prophylaxis as an additional measure to reduce the incidence of wound infection. 4'7'17 In neurosurgery, the introduction of longer microsurgical procedures and the increasing use of implanted foreign ma-R. Bullock, et al.
terials such as shunts, clips, and cranioplasty plates has increased the theoretical risk of perioperative infection. TM Many neurosurgeons are, however, reluctant to accept that perioperative prophylactic antibiotics may constitute a safe and effective means of reducing the incidence of wound infection.
Burke's guinea-pig studies, 2 in which wounds were inoculated with fixed doses of organisms and treated with systemic antibiotics at varying intervals before and after wound inoculation, have shown that antibiotic agents administered more than 3 hours after inoculation of the wound had a minimal effect in suppressing infection. He found that maximum protection was achieved when antibiotics were given prior to wound inoculation. These findings have been verified by clinical studies. Wright, 2~ in a major review of neurosurgical patients given antibiotics following various forms of surgery, concluded in 1966 that postoperative antibiotics conferred no benefit in minimizing wound infection after clean procedures. Price and Sleigh 13 noted the emergence of dangerous multiresistant nosocomial organisms in neurosurgical patients under intensive care and attributed it to the widespread use of postoperative antibiotic therapy following clean neurosurgical procedures and head injury. It is unlikely, however, that antibiotics given only for short periods perioperatively have any propensity to promote the selection of antibiotic-resistant strains of organisms. 8 The ideal antimicrobial agent for use in neurosurgical prophylaxis has not yet been established. We chose piperacillin because of its broad-spectrum antimicrobial activity, its bactericidal effect, and its rapid and effective passage through the blood-brain barrier into the brain and meninges. 3 Piperacillin may, however, be poorly effective against beta-lactamase-producing staphylococcal strains. In instances where such strains are an important component of normal hospital flora, a cephalosporin or a penicillinase-resistant agent such as methicillin or nafcillin (or a combination of these) may be more effective for antibiotic prophylaxis. In cases where postoperative sepsis is caused almost exclusively by beta-lactamase-producing staphylococcal organisms, as in post-shunt sepsis, certain authors have suggested the use of single agents such as methicillin and nafcillin, with maximum activity against penicillinase-producing Staphylococci. L~2 '19 Bacteriological surveillance of the resistance patterns of Staphylococci in our institution prior to the commencement of this study revealed a very low incidence of penicillinase-producing organisms, which influenced our choice of agent.
Although prophylactic antibiotics can never compensate for inadequate surgical technique, the results of this study show that they can reduce the incidence of neurosurgical wound infection.
